Lever Bio
Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
$10.09M Seed ·
Source: leverbio.com
Funding history ↓Signals
Website registeredApr 20, 2024 (2 years old)
Funding rounds
- Seed · $10.09MSource: leverbio.com
- Website created
Companies like Lever Bio
DDomain Therapeutics$41M Series A · May 2022
HHaptena Therapeutics$3.53M Seed · Dec 2025RRondo Therapeutics$67M Series A · Mar 2022
MMeta-FluxSeed · Oct 2025
LLunaphoreSeries B+ · Mar 2023BBlazar
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lever-bio (get a free API key).